The Confusion Over A Pair Of Diabetes Drugs And Pancreatitis

Will yet another study about the risk of pancreatitis spell trouble for some diabetes drugs? The latest instance involves a paper that was published in JAMA Internal Medicine and indicates that Merck’s Januvia and Bristol-Myers Squibb’s Byetta can double the risk of developing pancreatitis. Yes, this is the same issue that, over the past few years, has plagued drugs that increase the GLP-1 hormone.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news